Bahamas vs Congo: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Bahamas
85.0%
in 2025
Congo
85.0%
in 2025
Bahamas rank
96th
Congo rank
96th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Bahamas
- Congo
How they compare
Bahamas currently reports 85.0% against 85.0% in Congo, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Congo ahead.
Bahamas ranks 96th and Congo ranks 96th of 194 countries.
Bahamas has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahamas | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.5% | 0.0% | 1.5% | Bahamas |
| 2010s | 69.3% | 53.4% | 15.9% | Bahamas |
| 2020s | 83.0% | 77.5% | 5.5% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Bahamas or Congo?
- Bahamas, at 85.0% against 85.0% in Congo as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Bahamas and Congo?
- 0.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Congo?
- 18 years are reported by both, from 2008 to 2025.
- How do Bahamas and Congo rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Bahamas ranks 96th and Congo ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.